Shares of McDermott International Inc (NYSE: MDR) have recovered after tumbling in early market trade. The shares fell sfter the company announced the completion of the spin-off of its power generation systems and government operations segments.
The company has finished the spinoff through the. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
Bioventus IPO Brings In $104M to Support Growing Medical Device Business
Medical device maker Bioventus is the latest North Carolina life sciences firm joining the public markets, raising $104 million from its initial public offering.
On Thursday, Durham-based Bioventus offered 8 million shares priced at $13 each. That price was less than the company planned. When Bioventus set initial IPO terms last week, it proposed selling 7.35 million shares in the range of $16 to $18 per share. Bioventus shares will trade on the Nasdaq exchange under the stock symbol “BVS.”
Bioventus develops and markets medical devices and biological products that address orthopedic conditions. The company was initially the biologics and clinical therapies unit of United Kingdom-based Smith & Nephew, a medical equipment company. In 2016, Smith & Nephew spun out Bioventus as a separate company with financial backing from healthcare investment firm Essex Woodlands.
Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2020; Introduces Fiscal Year 2021 Revenue Guidance
January 14, 2021 06:30 ET | Source: Venus Concept Inc. Venus Concept Inc. San Jose, California, UNITED STATES
TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2020 and introduced revenue guidance expectations for the twelve months ended December 31, 2021.
Management Commentary:
“We continued to see improvements in the operating environment in our key markets in the fourth quarter as evidenced by the 22% to 27% growth quarter-over-quarter implied by our preliminary revenue range,” said Domenic Serafino, Chief Executive Officer of Venus Concept. “The improvement in growth trends as compared to the t
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Venus Concept Announces Debt Refinancing
Venus Concept Inc.December 10, 2020 GMT
TORONTO, Dec. 10, 2020 (GLOBE NEWSWIRE) Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has amended its existing revolving credit facility with City National Bank of Florida (“CNB”) and successfully refinanced its long-term debt obligations. Specifically, the Company secured a new loan with CNB in the aggregate amount of $50.0 million as part of the Main Street Priority Loan Facility established by the Board of Governors of the Federal Reserve System Section 13(3) of the Federal Reserve Act. The loan has a term of five years and bears interest at an annual rate of LIBOR plus 3%. A portion of the proceeds were used to pay down $3.2 million of the Company’s revolving line of credit with CNB. The Company